1. Home
  2. Faculty

Ali Jabbari, MD, PhD

Professor of Dermatology

Current Positions

  • The John S. Strauss Endowed Chair in Dermatology
  • Chair and DEO, Department of Dermatology
  • Professor of Dermatology

Education

  • BA in Molecular & Cell Biology, University of California, Berkeley, Berkeley, California, United States
  • MD/PhD in Medicine-Immunology, University of Iowa, Iowa City, Iowa, United States
  • Internship in Internal Medicine, UT Southwestern, Dallas, Texas
  • Sulzberger Research Fellowship in Immunodermatology, Rockefeller University, New York, New York
  • Resident in Dermatology, New York University, New York, New York

Graduate Program Affiliations

Research Interests

  • Alopecia areata
  • Cutaneous T cell lymphoma

Licenses & Certifications

  • Iowa State Medical
  • Texas State Medical, Texas, United States
  • Fellow, American Academy of Dermatology
  • Diplomat, American Board of Dermatology

Selected Publications

  • Borcherding, N., Crotts, S. B., Ortolan, L. S., Henderson, N., Bormann, N. L. & Jabbari, A. (2020). A transcriptomic map of murine and human alopecia areata. JCI insight 5 (13). DOI: 10.1172/jci.insight.137424. PMID: 32453712. PMCID: PMC7406251.
  • Thompson, H. J., Vavra, T. & Jabbari, A. (2020). Factors associated with insurance coverage of tofacitinib for alopecia areata: A retrospective review from an academic institution. Journal of the American Academy of Dermatology. DOI: 10.1016/j.jaad.2020.06.028. PMID: 32553634.
  • Richey, P., Holt, M., Crotts, S. & Jabbari, A. (2019). Pretibial dystrophic epidermolysis bullosa associated with aberrant exon splicing of type VII collagen. (Vols. 5). (9), pp. 779-781. JAAD case reports. DOI: 10.1016/j.jdcr.2019.06.032. PMID: 31516996. PMCID: PMC6728729.
  • Ortolan, L. S., Kim, S. R., Crotts, S., Liu, L. Y., Craiglow, B. G., Wambier, C., Paschoal, R. S., King, B. A. & Jabbari, A. (2019). IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans. The Journal of allergy and clinical immunology. DOI: 10.1016/j.jaci.2019.08.014. PMID: 31470035.
  • Petukhova, L., Patel, A. V., Rigo, R. K., Bian, L., Verbitsky, M., Sanna-Cherchi, S., Erjavec, S. O., Abdelaziz, A. R., Cerise, J. E., Jabbari, A. & Christiano, A. M. (2019). Integrative analysis of rare copy number variants and gene expression data in alopecia areata implicates an aetiological role for autophagy. Experimental dermatology. DOI: 10.1111/exd.13986. PMID: 31169925.
  • Borcherding, N., Voigt, A. P., Liu, V., Link, B. K., Zhang, W. & Jabbari, A. (2019). Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (10) 2996-3005. DOI: 10.1158/1078-0432.CCR-18-3309. PMID: 30718356. PMCID: PMC6659117.
  • Concha JSS, Patsatsi, A., Marshak-Rothstein, A., Liu, M. L., Sinha, A. A., Lee, L. A., Merola, J. F., Jabbari, A., Gudjonsson, J. E., Chasset, F., Jarrett, P., Chong, B., Arkin, L., Fernandez, A. P., Caproni, M., Greenberg, S. A., Kim, H. J., Pearson, D. R., Femia, A., Vleugels, R. A., Fiorentino, D., Fujimoto, M., Wenzel, J. & Werth, V. P. (2019). Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations. The Journal of investigative dermatology 139 (2) 270-276. DOI: 10.1016/j.jid.2018.08.017. PMID: 30243657. PMCID: PMC6394859.
  • Jabbari, A., Sansaricq, F., Cerise, J., Chen, J. C., Bitterman, A., Ulerio, G., Borbon, J., Clynes, R., Christiano, A. M. & Mackay-Wiggan, J. (2018). An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis. J Invest Dermatol 138 1539. DOI: 10.1016/j.jid.2018.01.032. PMID: 29452121.
  • Kennedy, C. M., Ko, J. M., Craiglow, B. G., Li, S., Shankar, G., Urban, J. R., Chen, J. C., Cerise, J. E., Jabbari, A., Winge, M. C., Marinkovich, M. P., Christiano, A. M., Oro, A. E. & King, B. A. (2016). Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI Insight 1 e89776. DOI: https://dx.doi.org/10.1172/jci.insight.89776. PMID: 27699252. PMCID: PMC5033755.
  • Mackay-Wiggan*, J., Jabbari*, A., Nguyen, N., Cerise, J. E., Clark, C., Ulerio, G., Furniss, M., Vaughn, R., Christiano, A. M. & Clynes, R. (2016). Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata. JCI Insight 1 e89790. DOI: https://dx.doi.org/10.1172/jci.insight.89790. PMID: 27699253. PMCID: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033756/.